吸烟和冠状动脉旁路移植后的患病和死亡的长期风险
Emelie Johansson1,2, Malin Stenman3,4, Emma C Hansson1,2
1Department of Molecular and Clinical Medicine, Sahlgrenska Academy, Gothenburg University, Gothenburg, Sweden.
International journal of cardiology. Cardiovascular risk and prevention
|December 30, 2025
概括
在冠状动脉旁路移植 (CABG) 后,吸烟显著增加了死亡率和主要不良心血管事件 (MACE) 的长期风险. 当前吸烟者面临的风险最高,这强调了在CABG后需要戒烟支持的必要性.
科学领域:
- 心脏病学 心脏病学
- 公共卫生 公共卫生
- 流行病学 流行病学
背景情况:
- 冠状动脉旁路移植 (CABG) 是心血管疾病的关键干预措施.
- 吸烟对CABG后结果的长期影响需要进一步调查.
- 了解吸烟相关风险对于患者管理和公共卫生战略至关重要.
研究的目的:
- 调查接受CABG的患者吸烟状态与长期发病率和死亡率之间的关联.
- 量化目前和前吸烟者的重大心血管不良事件 (MACE),全因死亡率和中风风险,与CABG后从未吸烟者的风险相比.
- 突出戒烟在改善CABG后患者治疗结果方面的重要性.
主要方法:
- 一个基于人口的注册表研究,利用来自SWEDEHEART注册表的数据.
- 包括27,434名在2010年至2020年期间接受CABG的患者,分为从未吸烟者,前吸烟者和目前吸烟者.
- 使用调整的考克斯回归模型进行分析,以估计死亡率和发病率的危险比率,随访时间中位数为5年.
主要成果:
- 与从未吸烟者相比,目前吸烟者对MACE (aHR 1.52),全因死亡率 (aHR 1.91) 和中风 (aHR 1.49) 的风险更高.
- 与前吸烟者相比,目前吸烟者患MACE (aHR 1.38),全因死亡率 (aHR 1.53) 和中风 (aHR 1.36) 的风险增加.
- 与从未吸烟者 (aHR 1.07) 或前吸烟者 (aHR 1.15) 相比,目前吸烟者没有发现心肌梗塞的显著增加风险.
结论:
- 吸烟与CABG后死亡率和发病率的长期风险增加之间存在着强烈的联系.
- 目前的吸烟者面临的风险最为严重,强调戒烟干预措施的急需性.
- 在CABG之前激励患者戒烟对于优化长期健康结果至关重要.
相关概念视频
Stress Prevention and Stress Management Techniques IV
210
Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...
210
Peripheral Artery Disease V: Postoperative Nursing Management
343
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
343
Coronary Artery Disease I: Introduction
843
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
843
Chronic Obstructive Pulmonary Disease
2.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.2K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
3.5K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.5K
Coronary Artery Disease V: Interprofessional Care
202
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
202


